In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...
U.S. military veterans face racial and ethnic inequities in access to Novo Nordisk's highly in-demand drugs for diabetes and weight loss, according to a review of patient data published on Monday, the ...
In September, the company officially relocated its headquarters from a 114,000-square-foot space in New York City to a ...
The Motley Fool on MSN23h
Is Viking Therapeutics a Buy on the Dip?an annual meeting highlighting progress in the weight loss arena. For example, during the event, AstraZeneca shared promising ...
20h
As open enrollment kicks off, employees may find an unpleasant surprise in their 2025 health insurance premiums. Increased adoption of GLP-1 drugs, rising catastrophic claims and other cost pressures ...
Executives from Impact Analytics and Carters Inc. discuss demographic shifts, changing compositions, weight loss drugs and ...
Pendulum Therapeutics latest innovation comes in the form of a GLP-1 probiotic, acting as an appetite suppressor and healthy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback